IMMUNOLOGICAL PROFILE LINKED CLINICAL APPEARANCE AND OUTCOME IN ADVANCED STAGE MANTLE CELL LYMPHOMA

被引：0
|
作者：
Todorovic, M. [1 ]
Mihaljevic, B. [1 ]
Balint, B. [2 ]
Kraguljac, N. [1 ]
Andjelic, B. [1 ]
Perunicic, B. [1 ]
Markovic, O. [1 ]
Petrovic, M. [1 ]
机构：
[1] Clin Ctr Serbia, Belgrade, Serbia
[2] Inst Med Res, Belgrade, Serbia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1694
引用
收藏
页码：649 / 650
页数：2
相关论文
共 50 条
  • [31] TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage
    Dong, Hua-Jie
    Zhou, Li-Tao
    Fang, Cheng
    Fan, Lei
    Zhu, Dan-Xia
    Wang, Yin-Hua
    Li, Jian-Yong
    Xu, Wei
    MEDICAL ONCOLOGY, 2012, 29 (03) : 2166 - 2173
  • [32] STAGE I & II MANTLE-CELL LYMPHOMA: CLINICAL OUTCOMES WITH COMBINED MODALITY THERAPY
    Bernard, M.
    Tsang, R. W.
    Le, L. W.
    Hodgson, D. C.
    Sun, A.
    Wells, W.
    Crump, M.
    Gospodarowicz, M. K.
    ANNALS OF ONCOLOGY, 2011, 22 : 161 - 161
  • [33] High ZAP-70 expression correlates with worse clinical outcome in mantle cell lymphoma
    D Hui
    L Dabbagh
    J Hanson
    H M Amin
    R Lai
    Leukemia, 2006, 20 : 1905 - 1908
  • [34] High ZAP-70 expression correlates with worse clinical outcome in mantle cell lymphoma
    Hui, D.
    Dabbagh, L.
    Hanson, J.
    Amin, H. M.
    Lai, R.
    LEUKEMIA, 2006, 20 (10) : 1905 - 1908
  • [35] Autologous Stem Cell Transplantation and Addition of Rituximab Independently Prolong Response Duration in Advanced Stage Mantle Cell Lymphoma
    Hoster, Eva
    Metzner, Bernd
    Forstpointner, Roswitha
    Pfreundschuh, Michael
    Truemper, Lorenz
    Hallek, Michael
    Woermann, Bernhard
    Duehrsen, Ulrich
    Gisselbrecht, Christian
    Kluin-Nelemans, Hanneke C.
    Van Hoof, Achiel
    Unterhalt, Michael
    Hiddemann, Wolfgang
    Dreyling, Martin H.
    BLOOD, 2009, 114 (22) : 362 - 363
  • [36] Clinicopathological and Immunohistochemical Profile of Mantle Cell Lymphoma: An Institutional Experience
    Mishra, Pritinanda
    Padhi, Somanath
    Ayyanar, Pavithra
    Samal, Swagatika
    Das Majumdar, Saroj
    Panigrahi, Ashutosh
    Sable, Mukund
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [37] Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma Profile Report
    Hoy, Sheridan M.
    McKeage, Kate
    BIODRUGS, 2011, 25 (03) : 193 - 195
  • [38] Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report
    Jo, Jae-Cheol
    Kim, Seok Jin
    Lee, Ho Sup
    Eom, Hyeon-Seok
    Lee, Soon Il
    Park, Yong
    Lee, Jeong-Ok
    Lee, Yoojin
    Yhim, Ho-Young
    Yang, Deok-Hwan
    Byun, Ja Min
    Kang, Hye Jin
    Kim, Hyo Jung
    Shin, Ho-Jin
    Yoo, Kwai Han
    Suh, Cheolwon
    ANNALS OF HEMATOLOGY, 2020, 99 (02) : 223 - 228
  • [39] Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report
    Jae-Cheol Jo
    Seok Jin Kim
    Ho Sup Lee
    Hyeon-Seok Eom
    Soon Il Lee
    Yong Park
    Jeong-Ok Lee
    Yoojin Lee
    Ho-Young Yhim
    Deok-Hwan Yang
    Ja Min Byun
    Hye Jin Kang
    Hyo Jung Kim
    Ho-Jin Shin
    Kwai Han Yoo
    Cheolwon Suh
    Annals of Hematology, 2020, 99 : 223 - 228
  • [40] Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
    Martin, Peter
    Chadburn, Amy
    Christos, Paul
    Weil, Karen
    Furman, Richard R.
    Ruan, Jia
    Elstrom, Rebecca
    Niesvizky, Ruben
    Ely, Scott
    DiLiberto, Maurizio
    Melnick, Ari
    Knowles, Daniel M.
    Chen-Kiang, Selina
    Coleman, Morton
    Leonard, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1209 - 1213
12345